Targeting STAT3 in cancer immunotherapy

S Zou, Q Tong, B Liu, W Huang, Y Tian, X Fu - Molecular cancer, 2020 - Springer
As a point of convergence for numerous oncogenic signaling pathways, signal transducer
and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune …

Pancreatic cancer stroma: an update on therapeutic targeting strategies

AN Hosein, RA Brekken, A Maitra - Nature reviews Gastroenterology & …, 2020 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality in
the Western world with limited therapeutic options and dismal long-term survival. The …

The role of collagen in cancer: from bench to bedside

S Xu, H Xu, W Wang, S Li, H Li, T Li, W Zhang… - Journal of translational …, 2019 - Springer
Collagen is the major component of the tumor microenvironment and participates in cancer
fibrosis. Collagen biosynthesis can be regulated by cancer cells through mutated genes …

IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma

G Biffi, TE Oni, B Spielman, Y Hao, E Elyada… - Cancer …, 2019 - aacrjournals.org
Pancreatic ductal adenocarcinoma (PDAC) is poorly responsive to therapies and
histologically contains a paucity of neoplastic cells embedded within a dense desmoplastic …

Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map

J Huynh, A Chand, D Gough, M Ernst - Nature Reviews Cancer, 2019 - nature.com
The tightly orchestrated temporal and spatial control of signal transducer and activator of
transcription 3 (STAT3) activity in epithelial, immune and stromal cells is critical for wound …

Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome …

J Datta, X Dai, A Bianchi, IDC Silva, S Mehra… - Gastroenterology, 2022 - Elsevier
Background & Aims We have shown that reciprocally activated rat sarcoma (RAS)/mitogen-
activated protein kinase/extracellular signal-regulated kinase (MEK) and Janus …

Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer

A Bianchi, I De Castro Silva, NU Deshpande… - Cancer …, 2023 - aacrjournals.org
We have shown that KRAS–TP53 genomic coalteration is associated with immune-excluded
microenvironments, chemoresistance, and poor survival in pancreatic ductal …

Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer

X Geng, H Chen, L Zhao, J Hu, W Yang, G Li… - Frontiers in cell and …, 2021 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease that typically features a
dramatic desmoplastic reaction, especially fibroblasts. The roles of cancer-associated …

Adaptive mechanisms of tumor therapy resistance driven by tumor microenvironment

P Wu, W Gao, M Su, EC Nice, W Zhang… - Frontiers in cell and …, 2021 - frontiersin.org
Cancer is a disease which frequently has a poor prognosis. Although multiple therapeutic
strategies have been developed for various cancers, including chemotherapy, radiotherapy …

[HTML][HTML] Microenvironmental determinants of pancreatic cancer

E Hessmann, SM Buchholz, IE Demir… - Physiological …, 2020 - journals.physiology.org
Pancreatic ductal adenocarcinoma (PDAC) belongs to the most lethal solid tumors in
humans. A histological hallmark feature of PDAC is the pronounced tumor microenvironment …